Biologic injections Scottsdale: plain help for a sore joint

Joint wear and a sore tendon can feel much alike

Muscle is fastened to bone by a tough band called a tendon. A tendon can get sore after more walking or reaching than usual. Joint wear, a sore tendon, and an old injury may all hurt in much the same way. They aren’t easy to tell apart. Sometimes shoulder soreness begins in the neck, or hip soreness begins in the back.

Here’s what matters. You’ll want to notice whether movement eases the ache or makes it build. Tell your doctor about swelling, weakness, locking, or motion you’ve lost. The exam can then sort out which body part is sore.

Gentle movement and a lighter load often help at home

Most soreness doesn’t require complete rest unless an injury makes movement unsafe. Do less of the chore or walk that brings on soreness. Keep the joint moving in a comfortable range, then add activity slowly. Planned exercise may help your strength and help you use the joint each day. When body weight adds pressure, losing some may help.

You can’t safely force a joint through sharp pain. If one busy day causes several hard days, do a little less next time. Home care may calm mild soreness, but it won’t tell you whether the ache starts inside the joint or in a tendon.

If soreness stays, QC Kinetix can go over non-surgical choices

When the ache keeps limiting you, an exam makes sense. QC Kinetix provides what it calls regenerative treatment options for soreness: non-surgical care such as platelet-rich plasma, called PRP. Making PRP starts with a small blood draw. The clinic spins it to collect platelets in less liquid. Those small parts of blood help form clots. A medical provider, one of the clinic staff who gives the treatment, puts the PRP into the sore joint as a shot.

No choice works for everyone. PRP results aren’t all the same, so ask which sore body part the exam identified and why this shot may fit. Ask too for the total price, likely soreness afterward, recovery time, later care, and any surgery choices.

Sources

1. A network meta-analysis restricted to LARGE randomized trials (at least 100 patients per group; 57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. In the main analysis excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11, 11 trials) but higher odds of dropouts due to adverse events (OR 2.01) and of serious adverse events (OR 1.86). The effects of 16 of the 18 interventions were smaller than the MID and most were consistent with placebo effects.

   Pereira TV, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.. Osteoarthritis and Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.

2. RESTORE, the largest and most rigorously blinded placebo-controlled PRP trial in knee OA (n=288, participant-, injector- and assessor-blinded), gave three weekly injections of a commercial leukocyte-poor PRP or saline. At 12 months the change in knee pain was -2.1 vs -1.8 points (difference -0.4; 95% CI -0.9 to 0.2; P=.17) and the change in medial tibial cartilage volume was -1.4% vs -1.2% (difference -0.2%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no between-group difference. The authors concluded the findings do not support the use of PRP for knee OA.

   Bennell KL, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial.. JAMA, 2021. DOI: 10.1001/jama.2021.19415.

3. A Bayesian network meta-analysis of 48 Level I-II randomized trials (9,338 knees) with a minimum 6-month follow-up ranked the four commonest intra-articular injections. HA and PRP both significantly improved pain versus placebo; HA, PRP and BMAC all significantly improved function versus placebo. SUCRA rankings were PRP 91.54, BMAC 76.46, HA 53.12, corticosteroid 15.18 and placebo 13.70 - corticosteroid ranked barely above placebo at six months and beyond.

   Jawanda H, et al. — Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.. Arthroscopy, 2024. DOI: 10.1016/j.arthro.2024.01.037.

4. A systematic mapping of the entire injectable knee OA literature since 1959 identified 766 clinical studies covering 75,834 patients: 11,245 treated with corticosteroid, 40,862 with hyaluronic acid, 16,174 with PRP and 7,553 with cell-based therapies. Hyaluronic acid still has the largest evidence base; PRP has recently overtaken corticosteroid in number of studies; placebo-controlled RCTs remain limited and only a negligible percentage of studies examined disease-modifying effects.

   Bensa A, et al. — Corticosteroids, hyaluronic acid, platelet-rich plasma, and cell-based therapies for knee osteoarthritis - literature trends are shifting in the injectable treatments' evidence: a systematic review and expert opinion.. Expert Opinion on Biological Therapy, 2025. DOI: 10.1080/14712598.2025.2465833.